Αρχική World News Quantitative Summary of QoL Data Confirms Immune Checkpoint Inhibitor Therapy Is Generally...

Quantitative Summary of QoL Data Confirms Immune Checkpoint Inhibitor Therapy Is Generally Well-Tolerated

Dr. Brian D. Gonzalez of Moffitt Cancer Center in Tampa, USA presented findings from two meta-analyses at ESMO Virtual Congress 2020 which were designed to summarise quality of life (QoL) data to better educate patients receiving immune checkpoint inhibitor (ICI) therapy for cancer. These meta-analyses found that patients receiving ICI had better QoL than patients receiving non-ICI treatment.

Dr Gonzalez reported findings on behalf of colleagues from this study, which was conducted with the aim of summarising QoL data to make QoL information more accessible to patients receiving ICI for cancer.

Patients treated with ICIs reported less change in QoL

The two meta-analyses were performed on publications of PD-1/PD-L1 and/or CTLA-4 inhibitors that provided mean-level QoL using the EORTC QLQ-C30 and/or EQ-5D questionnaires. One meta-analysis examined change in QoL in patients treated with ICIs from pre-treatment to follow-up, which occurred approximately 12 to 24 weeks later. The second meta-analysis compared QoL at follow-up between ICI and non-ICI regimens in randomised trials. Both had moderator analyses examining ICI regimen, comparator regimen, disease site, age, gender, follow-up period and risk of bias.

The investigators identified 20,323 publications, of which 26 studies met the inclusion criteria.

The first meta-analysis, which comprised 26 studies and 6,965 patients, indicated that QoL did not change over time in patients following ICI treatment (p > 0.05). Some subgroups reported improvements in QoL, such as patients treated with certain ICIs or for certain cancer types. Other significant moderators included sex and risk of bias (p values < 0.05).


Overall, quality of life did not change after ICI treatment, but changes were evident in some subgroups.

© Brian D. Gonzalez.

The second meta-analysis consisted of 16 studies and 6,536 patients; among these patients, 3,588 received ICI treatment and 2,948 patients received other, non-ICI therapy.  Better follow-up QoL was observed in patients receiving ICI versus non-ICI regimens (p < 0.05). Significant moderators in this analysis included ICI regimen, cancer type, age and risk of bias (p values < 0.05).


The authors noted that their study is among the first to quantitatively summarise QoL in patients treated with ICIs.

These findings suggest that patients treated with ICIs have more stable and better QoL overall than patients treated with non-ICI regimens for similar cancer.

They concluded that these results confirm that, despite immune-related toxicities, ICIs are generally well-tolerated.

Funding for this study was reported from the US National Cancer Institute (grant K01 CA211789).


1568O – Gonzalez BD, Eisel SL, Bowles KE, et al. Quality of life in cancer patients treated with immune checkpoint inhibitors: A meta-analysis. ESMO Virtual Congress 2020.



Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

Targeted Therapy Based on Molecular Profiling of Malignant Mesothelioma Tumours Is Feasible

Targeted therapy recommendations can be made based on the molecular profiles of tumour samples from patients with metastatic malignant mesothelioma (MM) according to findings...

News digest – targeted radiation beam, precision medicine and our early detection roadmap

<img width="620" height="348" src="https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1.jpg" class="attachment-hero size-hero" alt srcset="https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1.jpg 620w, https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1-300x168.jpg 300w, https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1-220x123.jpg 220w, https://zniup3zx6m0ydqfpv9y6sgtf-wpengine.netdna-ssl.com/wp-content/uploads/2020/10/Radiation_hero-1-150x84.jpg 150w" sizes="(max-width: 620px) 100vw, 620px" data-attachment-id="18059" data-permalink="https://scienceblog.cancerresearchuk.org/2020/10/17/news-digest-targeted-radiation-beam-precision-medicine-and-our-early-detection-roadmap/radiation_hero-3/" data-orig-file="https://scienceblog.cancerresearchuk.org/wp-content/uploads/2020/10/Radiation_hero-1.jpg" data-orig-size="620,348" data-comments-opened="1"...

A Pet Pug Helped Two Sisters Realize They Both Had Breast Cancer

Sisters Amanda Tasca and Amy Niosi are grateful for one very perceptive pug. Amanda’s dog Daisy, a gift from her husband Steve and one...

Woman with Breast Cancer May Have Saved Her Twin’s Life by Revealing Her Lumpectomy Scar

When Meagan McCallum was diagnosed with breast cancer, she had no idea that her experience might actually save her sister’s life. Meagan underwent a...

Lo que debe saber sobre el cáncer de pulmón

La Dra. Jyoti D. Patel es profesora de Medicina y directora de Oncología Torácica de la Universidad de Chicago y es editora asociada para...

Alternatives for Outdoor Foods

Autumn has arrived, but that doesn’t mean outdoor dining has to end! You might be wondering what foods you could prepare that are healthy...